How To Address The ‘Shocking Tale Of Neglect’ In Aged Care Through Transparency, Accountability, And The Use Of High-Quality Analytics
Funder
National Health and Medical Research Council
Funding Amount
$1,337,350.00
Summary
The Royal Commission into Aged Care shows that an improved understanding of how the aged care sector is caring for older Australians is a national priority. The Registry of Senior Australians, a large-scale registry database that I developed, will be used to evaluate the health and wellbeing of older Australians. This research will enable me to develop and implement a transparent outcome monitoring system and tools to address the “Shocking Tale of Neglect” older Australians are experiencing.
Advancing Health Economic Evaluation Measurement And Design To Support Priority Setting For Vulnerable Children
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
I bring well developed and unique research skills in child health economics, which is concerned with making sure the health system runs fairly and without waste. This research will make significant advancements in economic evaluation methods to ensure we can fairly evaluate health interventions for children. It will assess equity in how health care is funded for children and provide new information to support a fairer health system for children.
Embedding Economics For Cost-effective Melanoma Prevention, Diagnosis And Treatment
Funder
National Health and Medical Research Council
Funding Amount
$1,074,900.00
Summary
Melanoma is the most deadly form of skin cancer, and it is on the rise in Australia. However, the rapidly increasing costs of treatment are not sustainable for the health system or patients who pay out of pocket. Using health economic evaluation, this program of work will focus on improving: the (1) prevention, (2) diagnosis, and (3) treatment of melanoma, to ensure better, more sustainable healthcare.
Targeted Approaches To Improve Health Outcomes In Severe Respiratory Disease
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Despite receiving optimal treatment, people with severe lung disease experience distressing symptoms, reduced quality of life and wellbeing, and poor health outcomes. This transformational research will investigate new treatment approaches: an integrated palliative care program and Nasal High Flow therapy at home, to identify benefits for people with lung disease. Additionally this research will examine how patients’ attitudes to illness distress and mental health affect wellbeing and health
Improving Patient-important Outcomes In Haemodialysis Through Validation And Implementation In Registries And Pragmatic Clinical Trials
Funder
National Health and Medical Research Council
Funding Amount
$408,082.00
Summary
Haemodialysis is the most common treatment for kidney failure but is associated with poor survival, high symptom burden and drastically reduced quality of life. Research often does not address these patient-important outcomes, thereby limiting our ability to discover effective interventions. This program aims to improve haemodialysis outcomes that are critically important to patients and clinicians through validation and implementation in clinical practice, registries and clinical trial.
Addressing Evidence Gaps And Developing A Novel Treatment To Reduce The Burden Of Post-traumatic Knee Osteoarthritis
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Arthritis caused by knee injury has a devastating personal and economic impact. Research is needed to develop strategies to prevent arthritis and improve outcomes for people living with arthritis. This research will improve treatment of knee injury to reduce arthritis risk, understand why some people are more likely to get knee arthritis, and develop a new treatment to improve outcomes for people living with knee arthritis. A clinical trial will determine if this treatment achieves this aim.
Patient-centred Volunteer Program For People With Dementia: A Stepped Wedge Cluster Randomised Controlled Trial Of The MyCare Ageing Program
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
The MyCare Ageing program provides hospitalised patients with dementia and/or delirium with tailored emotional and practical support via trained volunteers in hospital and in the transition home. This project will provide critical information on whether MyCare Ageing works to reduce future hospitalisations and prevent poor patient outcomes, the factors that impact on how the program is delivered in hospital and in the community, and whether the program is cost-effective.
Delineating The Role Of Fludrocortisone And Hydrocortisone In The Management Of Patients With Septic Shock
Funder
National Health and Medical Research Council
Funding Amount
$553,664.00
Summary
Sepsis and septic shock are leading causes of morbidity and mortality globally. Steroids have been used to treat septic shock for decades. Two new trials, one using hydrocortisone vs. placebo and another using hydrocortisone plus fludrocortisone vs. placebo have produced differing results, with fludrocortisone possibly conferring a mortality benefit. My Program will investigate this evidence gap by providing critical evidence for the design and execution of a future definitive trial.
The Implementation And Evaluation Of Living Evidence In The Management Of Chronic Kidney Disease.
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Chronic kidney disease (CKD) is a growing health problem. Improving outcomes for patients with CKD requires the translation of research into clinical care. However, scientific research that underpins the management of CKD has rapidly increased, and traditional methods to summarise and inform clinical care are out of date. This project will develop, evaluate, and implement a new approach, known as ‘living-evidence’, that translates research evidence in real-time into the management of patients.
Improved Early Respiratory Support Of Infants And Children
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Worldwide respiratory disease in children has the highest health care burden on society. Children aged <5 years in particular, are increasing in hospital admissions and to intensive care where the cost is elevated. New ways of oxygen therapy have been studied and shown that we can reduce ICU admission if a therapy known as Nasal High Flow (NHF) therapy is applied earlier in the progression of the disease. Further research is needed in NHF therapy and to improve upon our patient outcomes.